Current state and future evolution of pancreatic islet transplantation
Open Access
- 8 October 2018
- journal article
- review article
- Published by Wiley in Annals of Gastroenterological Surgery
- Vol. 3 (1) , 34-42
Abstract
Pancreatic islet transplantation provides an effective treatment option for patients with type 1 diabetes (T1D) with intractable impaired awareness of hypoglycemia and severe hypoglycemic events. Currently, the primary goal of islet transplantation should be excellent glycemic control without severe hypoglycemia, rather than insulin independence. Islet transplant recipients were less likely to achieve insulin independence, whereas solid pancreas transplant recipients substantially had greater procedure‐related morbidity. Excellent therapeutic effects of islet transplantation as a result of accurate blood glucose level–reactive insulin secretion, which cannot be reproduced by current drug therapy, have been confirmed. Recent improvement of islet transplantation outcome has been achieved by refinement of the pancreatic islet isolation technique, improvement of islet engraftment method, and introduction of effective immunosuppressive therapy. A disadvantage of islet transplantation is that donors are essential, and donor shortage has become a hindrance to its development. With the development of alternative transplantation sites and new cell sources, including porcine islet cells and embryonic stem/induced pluripotent stem (ES/iPS)‐derived β cells, “On‐demand” and “Unlimited” cell therapy for T1D can be established.Keywords
Funding Information
- Japan Society for the Promotion of Science (18K08593)
- Ministry of Health, Labour and Welfare
This publication has 65 references indexed in Scilit:
- CXCR1/2 inhibition enhances pancreatic islet survival after transplantationJournal of Clinical Investigation, 2012
- Anakinra Potentiates the Protective Effects of Etanercept in Transplantation of Marginal Mass Human Islets in Immunodeficient MiceAmerican Journal of Transplantation, 2012
- Prediction of Pancreatic Tissue Densities by an Analytical Test Gradient System Before Purification Maximizes Human Islet Recovery for Islet Autotransplantation/AllotransplantationTransplantation, 2011
- A health economic analysis of clinical islet transplantationClinical Transplantation, 2011
- 2011 Update on Pancreas Transplantation: Comprehensive Trend Analysis of 25,000 Cases Followed Up Over the Course of Twenty-Four Years at the International Pancreas Transplant Registry (IPTR)The Review of Diabetic Studies, 2011
- Epidemiology of Type 1 DiabetesEndocrinology and Metabolism Clinics of North America, 2010
- Islet Transplantation in Type 1 Diabetics Using an Immunosuppressive Protocol Based on the Anti-LFA-1 Antibody EfalizumabAmerican Journal of Transplantation, 2010
- High-mobility group box 1 is involved in the initial events of early loss of transplanted islets in miceJournal of Clinical Investigation, 2010
- Intramuscular Autotransplantation of Pancreatic Islets in a 7-Year-Old Child: A 2-Year Follow-UpAmerican Journal of Transplantation, 2007
- Islet Surface Heparinization Prevents the Instant Blood-Mediated Inflammatory Reaction in Islet TransplantationDiabetes, 2007